EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study

Masato Okada iD, Koichi Inoue iD, Nobuaki Tanaka iD, Koji Tanaka iD, Yuko Hirao iD, Katsuomi Iwakura iD, Yasuyuki Egami iD, Masaharu Masuda iD, Tetsuya Watanabe, Hitoshi Minamiguchi iD, Takafumi Oka iD, Shungo Hikoso iD und 6 weitere

Europace · 2024

DOI: 10.1093/europace/euae120 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Europace, 2024. Verfasst von Masato Okada und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Centre, Sakurabashi Watanabe Hospital, 2-4-32 Umeda, Kita-ku, Osaka 530-0001, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Thrombosis, Echocardiography, Transesophageal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Blood stasis is crucial in developing left atrial (LA) thrombi. LA appendage peak flow velocity (LAAFV) is a quantitative parameter for estimating thromboembolic risk. However, its impact on LA thrombus resolution and clinical outcomes remains unclear. Methods and results The LAT study was a multicentre observational study investigating patients with atrial fibrillation (AF) and silent LA thrombi detected by transoesophageal echocardiography (TEE). Among 17 436 TEE procedures for patients with AF, 297 patients (1.7%) had silent LA thrombi. Excluding patients without follow-up examinations, we enrolled 169 whose baseline LAAFV was available. Oral anticoagulation use increased from 85.7% at baseline to 97.0% at the final follow-up (P < 0.001). During 1 year, LA thrombus resolution was confirmed in 130 (76.9%) patients within 76 (34–138) days. Conversely, 26 had residual LA thrombi, 8 had thromboembolisms, and 5 required surgical removal. These patients with failed thrombus resolution had lower baseline LAAFV than those with successful resolution (18.0 [15.8–22.0] vs. 22.2 [17.0–35.0], P = 0.003). Despite limited predictive power (area under the curve, 0.659; P = 0.001), LAAFV ≤ 20.0 cm/s (best cut-off) significantly predicted failed LA thrombus resolution, even after adjusting for potential confounders (odds ratio, 2.72; 95% confidence interval, 1.22–6.09; P = 0.015). The incidence of adverse outcomes including ischaemic stroke/systemic embolism, major bleeding, or all-cause death was significantly higher in patients with reduced LAAFV than in those with preserved LAAFV (28.4% vs. 11.6%, log-rank P = 0.005).

Conclusion

Failed LA thrombus resolution was not rare in patients with AF and silent LA thrombi. Reduced LAAFV was associated with failed LA thrombus resolution and adverse clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial AppendageThrombosisEchocardiography, TransesophagealAnticoagulantsHumansMaleFemaleAgedMiddle AgedBlood Flow VelocityRisk FactorsTreatment OutcomeAsymptomatic DiseasesTime FactorsHeart DiseasesThromboembolismAged, 80 and overAtrial Function, Left

Stichwörter der Autor:innen

Atrial fibrillationLeft atrial appendage flow velocityLeft atrial thrombusOral anticoagulantTransesophageal echocardiography

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Cardiovascular Centre, Sakurabashi Watanabe Hospital, 2-4-32 Umeda, Kita-ku, Osaka 530-0001, Japan.
  • Cardiovascular Division, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Division of Cardiology, Osaka Rosai Hospital, Osaka, Japan.
  • Cardiovascular Centre, Kansai Rosai Hospital, Amagasaki, Japan.
  • Division of Cardiology, Osaka General Medical Centre, Osaka, Japan.
  • Cardiovascular Division, Osaka Police Hospital, Osaka, Japan.

ORCID-Profile: Masato Okada, Koichi Inoue, Nobuaki Tanaka, Koji Tanaka, Yuko Hirao, Katsuomi Iwakura, Yasuyuki Egami, Masaharu Masuda, Hitoshi Minamiguchi, Takafumi Oka, Shungo Hikoso, Akihiro Sunaga, Katsuki Okada, Daisaku Nakatani, Yohei Sotomi, Yasushi Sakata

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Okada, M., Inoue, K., Tanaka, N., Tanaka, K., Hirao, Y., Iwakura, K., Egami, Y., Masuda, M., Watanabe, T., Minamiguchi, H., Oka, T., Hikoso, S., Sunaga, A., Okada, K., Nakatani, D., Sotomi, Y., Sakata, Y., & Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators (2024). Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study. Europace. https://doi.org/10.1093/europace/euae120

Vancouver

Okada M, Inoue K, Tanaka N, Tanaka K, Hirao Y, Iwakura K, et al. Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study. Europace. 2024. doi:10.1093/europace/euae120

BibTeX
@article{Okada2024,
  author = {Okada, Masato and Inoue, Koichi and Tanaka, Nobuaki and Tanaka, Koji and Hirao, Yuko and Iwakura, Katsuomi and Egami, Yasuyuki and Masuda, Masaharu and Watanabe, Tetsuya and Minamiguchi, Hitoshi and Oka, Takafumi and Hikoso, Shungo and Sunaga, Akihiro and Okada, Katsuki and Nakatani, Daisaku and Sotomi, Yohei and Sakata, Yasushi and Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators, Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators},
  title = {Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae120}
}
Kostenlos starten →